Evidence map›Paper›PMID 20180099›Full record

ArticleCalcified tissue international2010

A mineral-rich extract from the red marine algae Lithothamnion calcareum preserves bone structure and function in female mice on a Western-style diet.

Muhammad Nadeem Aslam, Jaclynn M Kreider, Tejaswi Paruchuri, Narasimharao Bhagavathula, Marissa DaSilva, Ronald F Zernicke, Steven A Goldstein, James Varani

Registry-linked trialAbstract read
In one paragraph

Article in Calcified tissue international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02647671 (The Effects of Calcium in Conjunction With Multi-mineral Supplementation), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02647671 phase1completednot on this mapstarted 2016, after this paper: background citation

The Effects of Calcium in Conjunction With Multi-mineral Supplementation (Aquamin) on Gut Microbes and Microbially-derived Metabolites in Subjects at Risk for Colon Cancer in a Randomized Controlled Trial

TypeinterventionalSponsorJames VaraniRan2016 to 2021Enrolled36ConditionsColonic CancerArmsAquamin®, Calcium Carbonate, Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 82 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Evaluation of dietary supplementation ofFrontiers in veterinary science · 2024
    Article
  7. Chemical-functional characterization ofFrontiers in veterinary science · 2024
    Article
  8. Bioactivity ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  9. Red Marine AlgaeMarine drugs · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Hexane Fraction ofFrontiers in endocrinology · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Muhammad Nadeem AslamDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Jaclynn M Kreider
Tejaswi Paruchuri
Narasimharao Bhagavathula
Marissa DaSilva
Ronald F Zernicke
Steven A Goldstein
James Varani
University of Michigan–Ann Arbor · US

Funding

Dietary Marine Algae Extract and Colon Cancer ChemopreventionR21CA140760 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI VARANI, JAMES · 2009 to 2010
$374k
NCI NIH HHS CA140760NCI NIH HHS R21 CA140760
6 · The paper itself

Abstract

The purpose of this study was to determine whether a mineral-rich extract derived from the red marine algae Lithothamnion calcareum could be used as a dietary supplement for prevention of bone mineral loss. Sixty C57BL/6 mice were divided into three groups based on diet: the first group received a high-fat Western-style diet (HFWD), the second group was fed the same HFWD along with the mineral-rich extract included as a dietary supplement, and the third group was used as a control and was fed a low-fat rodent chow diet (AIN76A). Mice were maintained on the respective diets for 15 months. Then, long bones (femora and tibiae) from both males and females were analyzed by three-dimensional micro-computed tomography (micro-CT) and (bones from female mice) concomitantly assessed in bone strength studies. Tartrate-resistant acid phosphatase (TRAP), osteocalcin, and N-terminal peptide of type I procollagen (PINP) were assessed in plasma samples obtained from female mice at the time of sacrifice. To summarize, female mice on the HFWD had reduced bone mineralization and reduced bone strength relative to female mice on the low-fat chow diet. The bone defects in female mice on the HFWD were overcome in the presence of the mineral-rich supplement. In fact, female mice receiving the mineral-rich supplement in the HFWD had better bone structure/function than did female mice on the low-fat chow diet. Female mice on the mineral-supplemented HFWD had higher plasma levels of TRAP than mice of the other groups. There were no differences in the other two markers. Male mice showed little diet-specific differences by micro-CT.

Indexed as

DietAnimal FeedAnimalsBone and BonesBone Density Conservation AgentsCell ExtractsDietary FatsDrug Evaluation, PreclinicalFemaleMaleMiceMice, Inbred C57BLMineralsOsmolar ConcentrationRhodophytaWestern WorldBone Density Conservation AgentsCell ExtractsDietary FatsMinerals

Identifiers

PMID20180099
PMCPMC2877502
OpenAlexW1990718089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.